API
< Back to situations

[PERSON]

Hans Gelderblom

Featured in 1 tracked story · first seen

Situations

[QUIET] [HEALTH] [US] [CN] [DE]

Pimicotinib development for TGCT

2 clusters · 3 sources · last updated

Latest: FDA approves pimicotinib for tenosynovial giant cell tumor

Clinical data from the phase 3 MANEUVER trial indicated that pimicotinib provides durable responses and sustained improvements for patients with tenosynovial giant cell tumor (TGCT). Findings presented at the ESMO Congre